Evidence mapPaperPMID 42497360Full record

Trial reportJMIR research protocols2026

Tailored Text Messaging Intervention to Improve Self-Care in Patients With Heart Failure (Text4HF): Protocol for a Pilot Randomized Controlled Trial.

Jonathan W Leigh, Susan J Pressler, Ben S Gerber, Mayank Kansal, Mia Cajita, Spyros Kitsiou

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in JMIR research protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jonathan W LeighDepartment of Biomedical and Health Information Sciences, College of Applied Health Sciences, University of Illinois Chicago, 1919 W. Taylor St., 250 AHSB, MC 530, Chicago, IL, 60612, United States, 1 312-996-7337, 1 312-996-8342.ORCID http://orcid.org/0000-0001-8769-9739
Susan J PresslerSchool of Nursing, Indiana University, Indianapolis, IN, United States.ORCID http://orcid.org/0000-0002-3739-7617
Ben S GerberUniversity of Massachusetts Chan School of Medicine, Worcester, MA, United States.ORCID http://orcid.org/0000-0003-4367-6396
Mayank KansalDepartment of Medicine, Division of Cardiology, University of Illinois Chicago, Chicago, IL, United States.ORCID http://orcid.org/0000-0003-2552-8744
Mia CajitaDepartment of Biobehavioral Nursing Science, College of Nursing, University of Illinois Chicago, Chicago, IL, United States.ORCID http://orcid.org/0000-0002-2331-1229
Spyros KitsiouDepartment of Biomedical and Health Information Sciences, College of Applied Health Sciences, University of Illinois Chicago, 1919 W. Taylor St., 250 AHSB, MC 530, Chicago, IL, 60612, United States, 1 312-996-7337, 1 312-996-8342.ORCID http://orcid.org/0000-0002-5281-321X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Heart failure (HF) is a major public health problem associated with frequent hospitalizations, high mortality, and substantial health care costs. Self-care is fundamental to improving health outcomes; yet, self-care is commonly poor among patients with HF. SMS text messaging interventions may provide a simple, scalable, and accessible strategy to support HF self-care, particularly among older adults who may face barriers to using more complex digital health technologies. However, the efficacy of text messaging as a standalone intervention for patients with HF remains underexplored. Objective: This protocol paper describes the rationale and design of a pilot randomized controlled trial examining the feasibility, acceptability, and preliminary efficacy of an individually Tailored Text Messaging Intervention to Improve Self-Care in Adults with HF (Text4HF). Methods: This study is a single-site, stage I, parallel-group randomized controlled trial. Participants (n=30) are community-dwelling adults aged 50 years or older with stage C HF and suboptimal self-care, defined as a score of 3 or less on at least 2 items of the Self-Care of Heart Failure Index (SCHFI v7.2). Participants are randomized (1:1) to either a 12-week tailored text messaging intervention (Text4HF) plus usual care or usual care alone. Text messages are triggered based on patient responses to validated instruments assessing evidence-based, modifiable behavioral factors of HF self-care. Feasibility (recruitment and retention) and acceptability of the intervention are assessed as key process outcomes. The main exploratory patient-reported outcome is HF self-care (SCHFI v7.2). Other patient-reported outcomes include medication adherence, adherence to a heart-healthy diet, HF knowledge, health-related quality of life, self-efficacy, and health beliefs. Results: This study was funded in June 2022, and participant recruitment began in September 2024. A total of 26 participants have been enrolled and randomized to the intervention (n=13) and control (n=13) groups. Participants have a mean age of 60 (SD 6.6) years, 46% (12/26) are female, and 73% (19/26) identify as non-Hispanic Black. Half of the participants are individuals with reduced ejection fraction. Study completion is anticipated in June 2026. Conclusions: This protocol describes an important step toward evaluating a scalable, low-cost text messaging intervention designed to improve self-care in patients with HF. Study findings will provide critical data on feasibility and acceptability to guide a future fully powered efficacy trial of Text4HF.

Indexed as

Heart FailureSelf CareText MessagingAdherence InterventionsAgedFemaleHumansMaleMiddle AgedPilot Projectsheart failuremHealthmobile healthrandomized controlled trialself-careSMStext messages

Identifiers

PMID42497360
PMCPMC13399410

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.